OMCL:NSD-Omnicell Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 30.28

Change

0.00 (0.00)%

Market Cap

USD 1.53B

Volume

0.73M

Analyst Target

USD 81.29
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital; and specialized automated dispensing systems for hospitals, health systems, and post-acute care facilities. It also provides central pharmacy dispensing services; IV compounding services; turnkey solution designed to help health systems establish, manage, and optimize an entity-owned specialty pharmacy, as well as support onsite management of specialty pharmacy services, including payer contracting, staffing, licensing, and 340B program administration. In addition, the company offers inventory optimization services comprising predictive and prescriptive analytics, benchmarking, workflow tools, and clinical resources, as well as medication inventory visibility; patient engagement, clinical, and financial solutions; medication adherence solutions, which include single-dose automation solutions, automated and semi-automated filling equipment, various medication blister card packaging and packaging supplies; and software that guides users through the manual filling process. Further, it provides professional services, such as technology installation, program management, customer education and training, change management services, and related offerings; technical services comprising post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; and retail pharmacy and hospital automation outside the United States business. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. The company was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-20 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
GEHC GE HealthCare Technologies Inc..

N/A

USD 28.76B
TEM Tempus AI, Inc. Class A Common..

N/A

USD 9.00B
HQY HealthEquity Inc

N/A

USD 7.52B
WAY Waystar Holding Corp. Common S..

N/A

USD 4.47B
BTSG BrightSpring Health Services, ..

N/A

USD 3.00B
PRVA Privia Health Group Inc

N/A

USD 2.92B
PINC Premier Inc

N/A

USD 1.93B
SDGR Schrodinger Inc

N/A

USD 1.79B
GDRX Goodrx Holdings Inc

N/A

USD 1.73B
CERT Certara Inc

N/A

USD 1.60B

ETFs Containing OMCL

ROBO Robo Global® Robotics an.. 0.00 % 0.00 %

N/A

USD 1.00B
ROBO Robo Global® Robotics an.. 0.00 % 0.95 %

N/A

USD 1.00B
SBB ProShares Short SmallCap6.. 0.00 % 0.95 %

N/A

N/A
SDD ProShares UltraShort Smal.. 0.00 % 0.95 %

N/A

N/A
DMRS 0.00 % 0.45 %

N/A

N/A
IJR:AU iShares Core S&P SmallCap.. 0.00 % 0.00 %

N/A

USD 0.54B
HDGE AdvisorShares Ranger Equi.. -0.03 % 2.52 %

N/A

USD 0.05B

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -31.99% 27% F 27% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -31.99% 27% F 26% F
Trailing 12 Months  
Capital Gain 8.80% 80% B- 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.80% 76% C+ 72% C
Trailing 5 Years  
Capital Gain -56.51% 50% F 23% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -56.51% 50% F 22% F
Average Annual (5 Year Horizon)  
Capital Gain -4.67% 53% F 30% F
Dividend Return -4.67% 53% F 29% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 58.08% 33% F 32% F
Risk Adjusted Return -8.04% 55% F 32% F
Market Capitalization 1.53B 77% C+ 78% C+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector